Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New License !!! - Extreme Networks
Reply New Message
Prev Message Back To Forum Threaded View Next Message

They're bigger than PTSC, but short of a billion dollar company.

For Fiscal 2012, the Company reiterated its previous guidance and expects net revenue to be in the range of $320-$340 million and non-GAAP net income to be in the range of $0.28- $0.35 per diluted share. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $0.04 on revenues of $79 million for the second quarter of 2012

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply